PROC - Procaps Group Net earnings per share (EPS TTM)

Symbol and logo of brand procapsgroup.com (PROC)

Management relies on stable demand in the medical sector, creating a defensive asset insulated from macroeconomic fluctuations. Earnings per share over the last 12 months demonstrate the results of this strategy, where 0.66 records a new level. The Colombian CDMO leader, Procaps Group S.A. (PROC), is implementing unique substance delivery methods, while high scalability through mass production for global brands ensures the payback of engineering costs.

PROC (Procaps Group S.A.) Net earnings per one share for the last twelve months history from 07/04/2022 to 02/16/2025

Comprehensive metric breakdowns and analytics for Procaps Group (PROC)

- share price and expert price forecast:
Stock Quotes Procaps Group S.A.|PROC - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Procaps Group|PROC - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Procaps|PROC - Total Stockholders' Equity|Market Value to Book Value Ratio procapsgroup.com|PROC - Aggregate Asset Value
- debt obligations and liquidity statistics:
Debt to Equity Procaps Group S.A.|PROC - Long-Term Liabilities to Equity|Short-Term Debt to Equity Procaps Group SA|PROC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Procaps Group|PROC - Long-Term Debt|Company Short-Term Debts Procaps|Quick Ratio procapsgroup.com
- net income and valuation multiples indicators:
PROC - Net Profit|Expected Profit Procaps Group S.A.|PROC - Market Cap to Net Income|Future Price to Earnings Procaps|PROC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Procaps Group|PROC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Procaps|PROC - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months procapsgroup.com|PROC - Earnings per share increase in current year|Net earnings per share growth forecast for next year Procaps Group S.A.
General company analysis:PROC - Procaps Group S.A.
Mass-produced product of Procaps Group SA

Logistics optimization for encapsulated drugs in Latin America provides Procaps Group S.A. (PROC) with high operational efficiency. The EPS TTM metric is calculated as the ratio of total annual net income to the number of shares outstanding. It determines the real return on a single share of capital, adjusted for the impact of issuance. Investors use this indicator to assess the fundamental value of the business. Analyzing the trailing twelve-month earnings per share slice on GURU.Markets helps identify whether the asset is overbought.

Main competitors

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia LQDA|GLPG (Galapagos N.V.) - Earnings per one share for the last 12 months|ANIP - Earnings per share for the last twelve months|Earnings per share for the trailing year MNKD (Afrezza)|Amphastar Pharmaceuticals (AMPH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months pacira.com (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Theravance Biopharma Inc (TBPH)|Net earnings per share (EPS TTM) AQST|Net earnings per share (EPS TTM) scpharmaceuticals.com (SCPH)|Earnings per share for the last twelve months Tectonic Therapeutic TECX|TNXP (tonixpharma.com) - Earnings per one share for the last 12 months|SXTC - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Eupraxia Pharmaceuticals EPRX|BHST (BioHarvest) - Net earnings per share for the last 12 months|Invizyne - Earnings per share for the trailing year|ORMP (Oramed) - Net earnings per share (EPS TTM)|ENTX - Net earnings per share for the trailing year|Earnings per share for the last twelve months MindWalk Holdings Inc. (HYFT)|ABVC (ABVC BioPharma Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Cumberland Pharma CPIX|Quantum BioPharma Corp (QNTM) - Net earnings per one share for the last twelve months|FGEN: Net earnings per share for the last 12 months|TELO - Net earnings per share (EPS TTM)|ranitherapeutics.com (RANI) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SNYR (Synergy CHC)|Net earnings per share for the last 12 months RLYB|LEXX: Earnings per share for the trailing year|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|Net earnings per share for the last four quarters ftzy.com.cn|Aptorum Group - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Lyra Therapeutics Inc. (LYRA)|Impact BioMedical Inc - Net earnings per share (EPS TTM)|TNFA - Net earnings per share (EPS TTM)|YCBD (cbdmd.com) - Net earnings per share for the last 12 months|PRFX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Altamira Therapeutics Ltd|Lipella Pharmaceuticals Inc - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Optinose (OPTN)|PIRS (Pieris Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals PTPI|qlsyy.net (QLI) - Net earnings per one share for the last twelve months|ACELYRIN - Net earnings per share (EPS TTM)|TFF Pharmaceuticals Inc. (TFFP) - Net earnings per share for the last 12 months